810 related articles for article (PubMed ID: 17234645)
1. The effects of dose, route, and repeated dosing on the disposition and kinetics of tetrabromobisphenol A in male F-344 rats.
Kuester RK; Sólyom AM; Rodriguez VP; Sipes IG
Toxicol Sci; 2007 Apr; 96(2):237-45. PubMed ID: 17234645
[TBL] [Abstract][Full Text] [Related]
2. Toxicokinetics of tetrabromobisphenol a in humans and rats after oral administration.
Schauer UM; Völkel W; Dekant W
Toxicol Sci; 2006 May; 91(1):49-58. PubMed ID: 16481339
[TBL] [Abstract][Full Text] [Related]
3. Absorption, distribution, metabolism and excretion of intravenously and orally administered tetrabromobisphenol A [2,3-dibromopropyl ether] in male Fischer-344 rats.
Knudsen GA; Jacobs LM; Kuester RK; Sipes IG
Toxicology; 2007 Jul; 237(1-3):158-167. PubMed ID: 17582672
[TBL] [Abstract][Full Text] [Related]
4. Disposition of a low dose of 14C-bisphenol A in male rats and its main biliary excretion as BPA glucuronide.
Kurebayashi H; Betsui H; Ohno Y
Toxicol Sci; 2003 May; 73(1):17-25. PubMed ID: 12700409
[TBL] [Abstract][Full Text] [Related]
5. Oral and topical absorption, disposition kinetics, and the metabolic fate of trans-methyl styryl ketone in the male Fischer 344 rat.
Sauer JM; Smith RL; Bao J; Kattnig MJ; Kuester RK; McClure TD; Mayersohn M; Sipes IG
Drug Metab Dispos; 1997 Jun; 25(6):732-9. PubMed ID: 9193875
[TBL] [Abstract][Full Text] [Related]
6. A rapid method to determine tetrabromobisphenol a in rat serum and urine by liquid chromatography-tandem mass spectrometry.
Kang MJ; Kim JH; Lee SK; Kang W; Kim HS; Lyoo WS; Jeong TC
Arch Pharm Res; 2010 Nov; 33(11):1797-803. PubMed ID: 21116783
[TBL] [Abstract][Full Text] [Related]
7. The absorption, distribution, metabolism and excretion of rofecoxib, a potent and selective cyclooxygenase-2 inhibitor, in rats and dogs.
Halpin RA; Geer LA; Zhang KE; Marks TM; Dean DC; Jones AN; Melillo D; Doss G; Vyas KP
Drug Metab Dispos; 2000 Oct; 28(10):1244-54. PubMed ID: 10997947
[TBL] [Abstract][Full Text] [Related]
8. Nephrotoxic potential and toxicokinetics of tetrabromobisphenol A in rat for risk assessment.
Kang MJ; Kim JH; Shin S; Choi JH; Lee SK; Kim HS; Kim ND; Kang GW; Jeong HG; Kang W; Chun YJ; Jeong TC
J Toxicol Environ Health A; 2009; 72(21-22):1439-45. PubMed ID: 20077216
[TBL] [Abstract][Full Text] [Related]
9. The disposition of radioactivity after administration of the anthelminthic methyl-14C-5-cyclopropylcarbonyl-2-benzimidazole carbamate (ciclobendazole) to rats and dogs.
Brodie RR; Mayo BC; Chasseaud LF; Hawkins DR
Arzneimittelforschung; 1977; 27(3):593-8. PubMed ID: 577426
[TBL] [Abstract][Full Text] [Related]
10. Disposition of decabromobiphenyl ether in rats dosed intravenously or by feeding.
el Dareer SM; Kalin JR; Tillery KF; Hill DL
J Toxicol Environ Health; 1987; 22(4):405-15. PubMed ID: 3694703
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of aminomethylpropanol in rats following oral and a novel dermal study design.
Saghir SA; Clark AJ; McClymont EL; Staley JL
Food Chem Toxicol; 2008 Feb; 46(2):678-87. PubMed ID: 17961896
[TBL] [Abstract][Full Text] [Related]
12. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.
Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K
Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117
[TBL] [Abstract][Full Text] [Related]
13. Disposition of the flame retardant 1,2-bis(2,4,6-tribromophenoxy)ethane in rats following administration in the diet.
Nomeir AA; Markham PM; Ghanayem BI; Chadwick M
Drug Metab Dispos; 1993; 21(2):209-14. PubMed ID: 8097687
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and disposition of the oxytocin receptor antagonist L-368,899 in rats and dogs.
Thompson KL; Vincent SH; Miller RR; Colletti AE; Alvaro RF; Wallace MA; Feeney WP; Chiu SH
Drug Metab Dispos; 1997 Oct; 25(10):1113-8. PubMed ID: 9321512
[TBL] [Abstract][Full Text] [Related]
15. Absorption, distribution, metabolism and excretion of YM466, a novel factor Xa inhibitor, in rats.
Mano Y; Sonoda T; Nakamura E; Usui T; Kamimura H
Biopharm Drug Dispos; 2004 Sep; 25(6):253-60. PubMed ID: 15334624
[TBL] [Abstract][Full Text] [Related]
16. Toxicokinetics of 14C-endosulfan in male Sprague-Dawley rats following oral administration of single or repeated doses.
Chan MP; Morisawa S; Nakayama A; Kawamoto Y; Sugimoto M; Yoneda M
Environ Toxicol; 2005 Oct; 20(5):533-41. PubMed ID: 16161119
[TBL] [Abstract][Full Text] [Related]
17. Absorption, disposition kinetics, and metabolic pathways of cyclohexene oxide in the male Fischer 344 rat and female B6C3F1 mouse.
Sauer JM; Bao J; Smith RL; McClure TD; Mayersohn M; Pillai U; Cunningham ML; Sipes IG
Drug Metab Dispos; 1997 Mar; 25(3):371-8. PubMed ID: 9172957
[TBL] [Abstract][Full Text] [Related]
18. Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.
Matsumoto S; Tagawa M; Amejima H; Nakao M; Kagemoto A; Fujii T; Miyazaki H; Sekine Y
Arzneimittelforschung; 1993 Oct; 43(10):1084-94. PubMed ID: 8267675
[TBL] [Abstract][Full Text] [Related]
19. In vivo bioavailability, absorption, excretion, and pharmacokinetics of [14C]procyanidin B2 in male rats.
Stoupi S; Williamson G; Viton F; Barron D; King LJ; Brown JE; Clifford MN
Drug Metab Dispos; 2010 Feb; 38(2):287-91. PubMed ID: 19910517
[TBL] [Abstract][Full Text] [Related]
20. Dose-dependent pharmacokinetics of 1-(2-deoxy-beta-D- ribofuranosyl)-2,4-difluoro-5-iodobenzene: a potential mimic of 5-iodo-2'-deoxyuridine.
Khalili P; Naimi E; Sun WY; Knaus EE; Wiebe LI
Biopharm Drug Dispos; 2003 Dec; 24(9):385-95. PubMed ID: 14689467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]